PBAC recommends daratumumab for newly diagnosed AL amyloidosis
Daratumumab (Darzalex®) could be the first ever therapy to be approved in Australia for AL amyloidosis.
- Amyloidosis
- Treatments and side-effects
Tag: Treatments and side-effects
New targeted treatment option available for Waldenström macroglobulinemia (WM) patients through PBS.
The Leukaemia Foundation has welcomed news that for the first time, a targeted treatment option will now be available for Waldenström macroglobulinemia (WM) patients through the Pharmaceutical Benefits Scheme (PBS).
- Other blood cancers
- Treatments and side-effects
Patients retain remission for 10+ years after CAR T-cell therapy
It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.
- Chronic lymphocytic leukaemia
- Treatments and side-effects
Jane’s had three different cancer diagnoses in two years
- Acute myeloid leukaemia
- Myelodysplastic syndromes
- Treatments and side-effects
Expert Series: Prof. John Pimanda – lots of work is needed to improve long-term outcomes for MDS
- Interviews with experts
- Myelodysplastic syndromes
- Treatments and side-effects
Katrina’s five-year delay in diagnosis was followed by a further wait for access to treatment.
- Treatments and side-effects
Support for submission to MSAC for MRD testing reimbursement in ALL
- Acute lymphoblastic leukaemia
- Treatments and side-effects
First CAR T-cell trial for myeloma a success for Andrew
Andrew was the first person in Western Australia to have the life-changing therapy.
- Clinical trials
- Myeloma
- Treatments and side-effects
New international trial for amyloidosis
In a first-ever Australian-French collaboration, an exciting new clinical trial, due to open before Christmas, will give Australians with relapsed or refractory AL amyloidosis access to a new drug combination.Â
- Amyloidosis
- Clinical trials
- Research
- Treatments and side-effects
Expert Series: Dr Piers Blombery on genomic testing
Dr Piers Blombery explains the basics of molecular testing which informs the treatment of blood cancer. Â
- Hodgkin lymphoma
- Interviews with experts
- Myeloma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
